{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T06:14:44Z","timestamp":1778652884990,"version":"3.51.4"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:p>Metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to as Non-alcoholic fatty liver disease (NAFLD), is among the most common chronic liver conditions globally. The incidence of MASLD has been rising, primarily due to lifestyle changes, excessive calorie intake, and other metabolic conditions like obesity and Type 2 diabetes mellitus in both adults and children. An inclusive understanding of risk factors of childhood MASLD is still unknown. Based on the limited case studies published, familial clustering is prominent in MASLD suggesting role of genetic factors. Moreover, children with MASLD are at higher risk of obesity, diabetes and hypertension. Studies associating the colonic microbiome with MASLD have been limited and complicated by inconsistencies in study design and approach but mostly indicate a role in the pediatric population. The present review provides a comprehensive understanding of the most recent clinical studies (2013\u20132026) on the role of gut microbiome in the development of pediatric MASLD.<\/jats:p>","DOI":"10.3389\/fped.2026.1773294","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:54:47Z","timestamp":1778651687000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Gut microbiota and pediatric metabolic dysfunction\u2013associated steatotic liver disease: clinical evidence and therapeutic implications"],"prefix":"10.3389","volume":"14","author":[{"given":"Bhagyalakshmi","family":"Nair","sequence":"first","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus","place":["Kochi, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adithya Jayaprakash","family":"Kamath","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus","place":["Kochi, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aswathy R.","family":"Devan","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus","place":["Kochi, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Gopalakrishna","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Amrita Institute of Medical Sciences and Research Centre","place":["Kochi, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashok R.","family":"Unni","sequence":"additional","affiliation":[{"name":"Central Lab Animal Facility, Amrita Institute of Medical Sciences","place":["Kochi, Kerala, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lekshmi R.","family":"Nath","sequence":"additional","affiliation":[{"name":"Department of Pharmacognosy, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus","place":["Kochi, India"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.jhep.2023.06.003","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"79","author":"Rinella","year":"2023","journal-title":"J Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"120551","DOI":"10.1016\/j.atherosclerosis.2025.120551","article-title":"Metabolic dysfunction-associated steatotic liver disease, cardiometabolic risk factors, and cardiovascular disease","volume":"411","author":"Kyhl","year":"2025","journal-title":"Atherosclerosis"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1444198","DOI":"10.3389\/fcell.2024.1444198","article-title":"Targeting hepatic macrophages for non-alcoholic fatty liver disease therapy","volume":"12","author":"Tian","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"104064","DOI":"10.1016\/j.drudis.2024.104064","article-title":"Unveiling the role of the Hedgehog signaling pathway in chronic liver disease: therapeutic insights and strategies","volume":"29","author":"Nair","year":"2024","journal-title":"Drug Discov Today"},{"key":"B6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1186\/s12876-025-04314-y","article-title":"Global prevalence of metabolic dysfunction-associated fatty liver disease in children and adolescents with overweight and obesity: a systematic review and meta-analysis","volume":"25","author":"Jia","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1468788","DOI":"10.3389\/fped.2025.1468788","article-title":"A bibliometric analysis of metabolic dysfunction-associated steatotic liver disease in children from 2004 to 2024","volume":"13","author":"Gong","year":"2025","journal-title":"Front Pediatr"},{"key":"B9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/cld.685","article-title":"Risk factors for progression of and treatment options for NAFLD in children","volume":"11","author":"Hartmann","year":"2018","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B10","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.clnu.2018.08.008","article-title":"Lean non-alcoholic fatty liver disease","volume":"38","author":"Wang","year":"2019","journal-title":"Clin Nutr"},{"key":"B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12664-020-01024-z","article-title":"Correlation between insulin resistance and liver histology in patients with nonalcoholic steatohepatitis with and without obesity","volume":"39","author":"Lazar","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nrgastro.2016.160","article-title":"Developmental origins of NAFLD: a womb with a clue","volume":"14","author":"Wesolowski","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cgh.2021.04.014","article-title":"Maternal and perinatal risk factors for pediatric nonalcoholic fatty liver disease: a systematic review","volume":"20","author":"Querter","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14691","DOI":"10.1073\/pnas.1005963107","article-title":"Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa","volume":"107","author":"De Filippo","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1417864","DOI":"10.3389\/fmicb.2024.1417864","article-title":"The microbiota: a crucial mediator in gut homeostasis and colonization resistance","volume":"15","author":"Chen","year":"2024","journal-title":"Front Microbiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s44324-025-00066-1","article-title":"Mechanisms and implications of the gut microbial modulation of intestinal metabolic processes","volume":"3","author":"Jyoti","year":"2025","journal-title":"Npj Metabolic Health and Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41392-022-00974-4","article-title":"Microbiota in health and diseases","volume":"7","author":"Hou","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1136\/gutjnl-2021-326789","article-title":"Gut microbiome and health: mechanistic insights","volume":"71","author":"De Vos","year":"2022","journal-title":"Gut"},{"key":"B19","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.amjms.2018.08.005","article-title":"Development of the pediatric gut microbiome: impact on health and disease","volume":"356","author":"Ihekweazu","year":"2018","journal-title":"Am J Med Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2463567","DOI":"10.1080\/19490976.2025.2463567","article-title":"Early life gut microbiome and its impact on childhood health and chronic conditions","volume":"17","author":"Nunez","year":"2025","journal-title":"Gut Microbes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1597206","DOI":"10.3389\/fnut.2025.1597206","article-title":"The early-life gut microbiome in common pediatric diseases: roles and therapeutic implications","volume":"12","author":"Bankole","year":"2025","journal-title":"Front Nutr"},{"key":"B22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41522-021-00265-w","article-title":"Gut microbiome development in early childhood is affected by day care attendance","volume":"8","author":"Amir","year":"2022","journal-title":"NPJ Biofilms Microbiomes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"815885","DOI":"10.3389\/fped.2022.815885","article-title":"The developing microbiome from birth to 3 years: the gut-brain axis and neurodevelopmental outcomes","volume":"10","author":"Laue","year":"2022","journal-title":"Front Pediatr"},{"key":"B24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1186\/s12887-025-06144-z","article-title":"The association between gut microbiota and metabolic dysfunction-associated steatotic liver disease (MASLD): a case-control study","volume":"25","author":"Rohani","year":"2025","journal-title":"BMC Pediatr"},{"key":"B25","doi-asserted-by":"publisher","first-page":"11294","DOI":"10.1038\/s41598-023-36533-2","article-title":"Gut-microbiota in children and adolescents with obesity: inferred functional analysis and machine-learning algorithms to classify microorganisms","volume":"13","author":"Squillario","year":"2023","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/1462-2920.13463","article-title":"Pediatric obesity is associated with an altered gut microbiota and discordant shifts in F irmicutes populations","volume":"19","author":"Riva","year":"2017","journal-title":"Environ Microbiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"15421","DOI":"10.3390\/ijms232315421","article-title":"The role of the gut microbiome in pediatric obesity and bariatric surgery","volume":"23","author":"Akagbosu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B28","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41591-020-0761-3","article-title":"Viable bacterial colonization is highly limited in the human intestine in utero","volume":"26","author":"Rackaityte","year":"2020","journal-title":"Nat Med"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/nm.3950","article-title":"Early life dynamics of the human gut virome and bacterial microbiome in infants","volume":"21","author":"Lim","year":"2015","journal-title":"Nat Med"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13568-020-01038-y","article-title":"Probiotic bifidobacterium lactis V9 attenuates hepatic steatosis and inflammation in rats with non-alcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"AMB Express"},{"key":"B31","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpeds.2018.11.021","article-title":"Prevalence of nonalcoholic fatty liver disease in children with obesity","volume":"207","author":"Yu","year":"2019","journal-title":"J Pediatr"},{"key":"B32","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1002\/cld.1027","article-title":"Epidemiology of pediatric nonalcoholic fatty liver disease","volume":"17","author":"Yu","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/hep.28572","article-title":"Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta-omics-based approach","volume":"65","author":"Del Chierico","year":"2017","journal-title":"Hepatology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","article-title":"Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH","volume":"57","author":"Zhu","year":"2013","journal-title":"Hepatology (Baltimore, Md.)"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.gastro.2019.06.028","article-title":"Microbiome signatures associated with steatohepatitis and moderate to severe fibrosis in children with nonalcoholic fatty liver disease","volume":"157","author":"Schwimmer","year":"2019","journal-title":"Gastroenterology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/pr.2018.32","article-title":"Gut microbiota in adolescents and the association with fatty liver: the EPOCH study","volume":"84","author":"Stanislawski","year":"2018","journal-title":"Pediatr Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsec\/fiu002","article-title":"Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease","volume":"91","author":"Michail","year":"2015","journal-title":"FEMS Microbiol Ecol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1111\/apt.12758","article-title":"Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non-alcoholic steatohepatitis","volume":"39","author":"Alisi","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"B40","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1111\/apt.14515","article-title":"Letter: what gastroenterologists should know about VSL #3","volume":"47","author":"De Simone","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1638372","DOI":"10.3389\/fcimb.2025.1638372","article-title":"Application of probiotic therapy in nonalcoholic fatty liver disease: mediating mechanism and future perspective","volume":"15","author":"Luo","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"170","DOI":"10.21037\/hbsn.2019.09.07","article-title":"Probiotics VSL#3 are effective in reversing non-alcoholic steatohepatitis in a mouse model","volume":"9","author":"Jena","year":"2020","journal-title":"Hepatobiliary Surg Nutr"},{"key":"B43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.clnu.2023.11.001","article-title":"Altered gut microbiome associated with metabolic-associated fatty liver disease in Chinese children","volume":"43","author":"Ji","year":"2024","journal-title":"Clin Nutr"},{"key":"B44","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2017.05.055","article-title":"Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity","volume":"153","author":"Nicolucci","year":"2017","journal-title":"Gastroenterology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jped.2013.07.003","article-title":"A randomized triple-masked controlled trial on the effects of synbiotics on inflammation markers in overweight children","volume":"90","author":"Kelishadi","year":"2014","journal-title":"J Pediatr (Rio J)"},{"key":"B46","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/mpg.0000000000001422","article-title":"Effects of probiotics on nonalcoholic fatty liver disease in obese children and adolescents","volume":"64","author":"Famouri","year":"2017","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e01148-24","DOI":"10.1128\/msystems.01148-24","article-title":"Multi-omics analyses of the gut microbiota and metabolites in children with metabolic dysfunction-associated steatotic liver disease","volume":"10","author":"Du","year":"2025","journal-title":"mSystems"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1773294\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:54:51Z","timestamp":1778651691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2026.1773294\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":47,"alternative-id":["10.3389\/fped.2026.1773294"],"URL":"https:\/\/doi.org\/10.3389\/fped.2026.1773294","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"article-number":"1773294"}}